In 2020, an unexpected outbreak swept the world.
The main pathogen causing the outbreak is SARS-CoV-2, a new virus that
researchers first identified in Wuhan province, China, in late 2019, and was
named by the World Health Organization on January 12, 2020. It is a pathogen
that mainly causes respiratory and intestinal diseases.
The epidemic coincided with the Spring Festival in 2020, and the development
was very fierce and spread widely. As an industrial national high-tech
enterprise for the detection and development of respiratory pathogens, our
company joined the "battle" as soon as possible and quickly organized
the strongest R & D force to succeed Develop high-sensitivity detection
kits to fight against viruses and help the frontline fight against epidemics!
Based on the
current epidemiological survey, the incubation period for 2019-nCoV is
generally 3-7 days, with a maximum of 14 days. The clinical manifestations of
the virus infection are: fever, fatigue, respiratory symptoms are mainly dry
cough, and dyspnea gradually develops; severe cases present with acute
respiratory distress syndrome, septic shock, metabolic acidosis and coagulation
that are difficult to treat; some patients have mild onset symptoms but no
fever; most patients have a good prognosis, and a few patients are in critical
condition or even die. The disease caused by the virus can be
manifested as simple infection, mild pneumonia, severe pneumonia, ARDS, sepsis,
and septic shock. According to the severity of clinical syndrome, it is divided
into mild, moderate and severe, the latter including severe pneumonia, ARDS,
sepsis and septic shock.
Based on
real-time fluorescent PCR technology, the results are produced within 1.5
hours.
The reaction
system of this kit contains a dU-UNG enzyme anti-pollution system to avoid
false positive results; the system contains internal standards to avoid false
negative results.
Sensitivity |
1.0x103copies/mL |
Linear range |
1.0x103copies/mL ~ 1.0x 109copies/mL |
Accuracy |
100% in enterprise references |
Precision |
Coefficient of variation (CV) ≤5% within and between batches |
Specificity |
No cross-reaction with coronavirus (NL63, HKU1, 229E, OC43), influenza A virus, influenza B virus, respiratory syncytial virus, adenovirus, mycoplasma pneumonia, and bordetella pertussis. |
Interference |
Not affect by Interferon (α-2b≤180 μg/mL), Hydroxymezoline hydrochloride spray(≤150 μg /mL), Budesonide nasal spray(≤256 g /mL), Erythromycin(≤50 mg/mL), Roxithromycin (≤7.5 mg/mL), Azithromycin (≤100mg/mL). |
Technical Principle:Real-time PCR
Packing: 24 tests/kit, 48 tests/kit, 96 tests/kit
Applicable instruments:ABI 7500,ABI 7300,Roche480,Roche96, etc.